In view of the current availability and estimated requirement of syringes for Covid-19 vaccination and Universal Immunisation Programme, it...

Rajiv Nath, President, All India Syringes and Needles Manufacturers Association (AiSNMA) urged the government to lift the restriction on no...

"Based on the safety and immunogenicity data of the phase 1 clinical trial, the company would be given permission for conducting phase 2 cl...

The government has said it will deploy its vast election machinery to deliver 60 crore doses of Covid vaccines to 30 crore Indians, includi...

India manufactures more than 60% of all vaccines sold across the globe, and while its $40 billion pharmaceutical sector is not yet involved...

Syringe manufacturers are hopeful of meeting the demand arising out of the upcoming Covid vaccination programme, but a lack of clarity on t...

"This is India's first phase-III efficacy study for a Covid-19 vaccine, and the largest phase-III efficacy trial ever conducted in India," ...

The discussion was held in the run up to a meeting of a committee of secretaries that will be chaired by Niti Aayog CEO Amitabh Kant.

The product will be marketed by Hetero Healthcare under the brand name ‘MaburaTM’ in India, the company said.

According to an industry executive who did not wish to be named, the domestically manufactured syringes and needles market together is esti...

CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm ...

The National Pharmaceutical Pricing Authority (NPPA) has begun scrutiny of such devices, even asking makers to log in every detail about th...

Kabir Khan's "Phantom" comes with the tagline 'A story you wish were true'. Perhaps a better one would have been 'A story you wish were mor...

It added that anti-dumping duty is already applicable on the 400 series grades to protect the domestic industry.

Company claims setting up first fully integrated PFS unit and expects to break-even in next two years, as the demand for PFS is rising.

The Indian arm of the US-based medical devices maker Becton Dickinson (BD) has dragged the health ministry and three companies to the court...

The government has decided to create separate quality guidelines for medical devices and not treat them as drugs.